“Moreover, luteolin treatment was found to reduce oxaliplatin-treated p53-null cell viability and colony counts further, thereby demonstrating an additional effect of luteolin in the killing of human colorectal tumor HCT116 cells not expressing functional p53 protein.”
“This study aimed to examine if luteolin , an Nrf2 activator, hinders chemotherapeutic activity of oxaliplatin , a potent anticancer agent for colorectal cancer, in HCT116 cells.”